SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-017210
Filing Date
2024-06-17
Accepted
2024-06-17 16:30:22
Documents
2
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 form4-06172024_040615.html 4  
1 form4-06172024_040615.xml 4 4152
2 ex24-06172024_040615.htm EX-24 8952
  Complete submission text file 0001415889-24-017210.txt   14526
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address
Xu Yuan (Reporting) CIK: 0001858214 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40925 | Film No.: 241048698